![](/img/cover-not-exists.png)
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting
Sant P. Chawla, Steven M. Grunberg, Richard J. Gralla, Paul J. Hesketh, Cindy Rittenberg, Mary E. Elmer, Carrie Schmidt, Arlene Taylor, Alexandra D. Carides, Judith K. Evans, Kevin J. HorganVolume:
97
Year:
2003
Language:
english
Pages:
11
DOI:
10.1002/cncr.11320
File:
PDF, 152 KB
english, 2003